If it feels like you have to grab the antihistamines and nasal sprays earlier than in years past, you're correct.

Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...

Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

Both the short-term and long-term use of nasal steroid sprays are thought to largely be safe for children and adults alike. However, they are not without side effects. This article reviews possible ...

The U.S. Food and Drug Administration (FDA) has announced significant advancements in medical treatments, including the approval of a novel gene therapy for a rare eye disease ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...

March 6, 2025 – The FDA has approved a new nose spray that can quickly treat severe allergic reactions in kids ages 4 and up ... Common side effects include nasal discomfort or tingling ...

Children as young as age 10 years can be taught how to use neffy. Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating ...

Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs. The FDA has approved ARS Pharmaceuticals’ neffy ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...